文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

通过模块化光点击化学实现的直接生物学平台加速 PROTACs 的发现。

Accelerating PROTACs Discovery Through a Direct-to-Biology Platform Enabled by Modular Photoclick Chemistry.

机构信息

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.

University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Adv Sci (Weinh). 2024 Jul;11(26):e2400594. doi: 10.1002/advs.202400594. Epub 2024 Apr 30.


DOI:10.1002/advs.202400594
PMID:38689503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11234393/
Abstract

Proteolysis targeting chimeras (PROTACs) have emerged as a promising strategy for drug discovery and exploring protein functions, offering a revolutionary therapeutic modality. Currently, the predominant approach to PROTACs discovery mainly relies on an empirical design-synthesis-evaluation process involving numerous cycles of labor-intensive synthesis-purification and bioassay data collection. Therefore, the development of innovative methods to expedite PROTAC synthesis and exploration of chemical space remains highly desired. Here, a direct-to-biology strategy is reported to streamline the synthesis of PROTAC libraries on plates, enabling the seamless transfer of reaction products to cell-based bioassays without the need for additional purification. By integrating amide coupling and light-induced primary amines and o-nitrobenzyl alcohols cyclization (PANAC) photoclick chemistry into a plate-based synthetic process, this strategy produces PROTAC libraries with high efficiency and structural diversity. Moreover, by employing this platform for PROTACs screening, we smoothly found potent PROTACs effectively inhibit triple-negative breast cancer (TNBC) cell growth and induce rapid, selective targeted degradation of cyclin-dependent kinase 9 (CDK9). The study introduces a versatile platform for assembling PROTACs on plates, followed by direct biological evaluation. This approach provides a promising opportunity for high-throughput synthesis of PROTAC libraries, thereby enhancing the efficiency of exploring chemical space and accelerating the discovery of PROTACs.

摘要

蛋白水解靶向嵌合体(PROTACs)作为一种有前途的药物发现和探索蛋白质功能的策略,提供了一种革命性的治疗模式。目前,PROTACs 发现的主要方法主要依赖于经验设计-合成-评估过程,涉及多次劳动密集型的合成-纯化和生物测定数据收集循环。因此,开发创新方法来加速 PROTAC 合成和探索化学空间仍然是非常需要的。在这里,报告了一种直接面向生物学的策略,以简化板上 PROTAC 文库的合成,无需额外的纯化即可将反应产物无缝转移到基于细胞的生物测定中。通过将酰胺偶联和光诱导的伯胺和邻硝基苄醇环化(PANAC)光点击化学集成到基于板的合成过程中,该策略以高效率和结构多样性产生 PROTAC 文库。此外,通过在该平台上进行 PROTAC 筛选,我们顺利地发现了有效的 PROTAC,能够有效抑制三阴性乳腺癌(TNBC)细胞的生长并诱导快速、选择性的靶向降解细胞周期蛋白依赖性激酶 9(CDK9)。该研究介绍了一种在板上组装 PROTAC 的多功能平台,随后进行直接的生物学评估。这种方法为 PROTAC 文库的高通量合成提供了一个有前途的机会,从而提高了探索化学空间的效率,并加速了 PROTAC 的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/79e015ab61d1/ADVS-11-2400594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/5fe23830a8c4/ADVS-11-2400594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/b8049436a443/ADVS-11-2400594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/569d9d40235f/ADVS-11-2400594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/e1fdd2d3129d/ADVS-11-2400594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/32e7a639d4aa/ADVS-11-2400594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/79e015ab61d1/ADVS-11-2400594-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/5fe23830a8c4/ADVS-11-2400594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/b8049436a443/ADVS-11-2400594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/569d9d40235f/ADVS-11-2400594-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/e1fdd2d3129d/ADVS-11-2400594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/32e7a639d4aa/ADVS-11-2400594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a462/11234393/79e015ab61d1/ADVS-11-2400594-g005.jpg

相似文献

[1]
Accelerating PROTACs Discovery Through a Direct-to-Biology Platform Enabled by Modular Photoclick Chemistry.

Adv Sci (Weinh). 2024-7

[2]
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs.

J Med Chem. 2023-11-23

[3]
Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple-negative breast cancer (TNBC).

Drug Dev Res. 2023-6

[4]
PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders.

J Adv Res. 2024-9

[5]
Natural product-based PROteolysis TArgeting Chimeras (PROTACs).

Nat Prod Rep. 2022-12-14

[6]
In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy.

Biomaterials. 2023-4

[7]
Expansion of targeted degradation by Gilteritinib-Warheaded PROTACs to ALK fusion proteins.

Bioorg Chem. 2024-4

[8]
Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation.

Chem Soc Rev. 2022-7-4

[9]
Photo-regulated PROTACs: A novel tool for temporal control of targeted protein degradation.

Bioorg Med Chem Lett. 2024-7-15

[10]
Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer.

Bioorg Chem. 2024-12

引用本文的文献

[1]
Methods to accelerate PROTAC drug discovery.

Biochem J. 2025-6-25

[2]
Light-Induced, Lysine-Targeting Irreversible Covalent Inhibition of the Human Oxygen Sensing Hydroxylase Factor Inhibiting HIF (FIH).

J Am Chem Soc. 2025-5-28

[3]
General Platform for Efficient and Modular Assembly of GalNAc-siRNA Conjugates via Primary Amines and -Nitrobenzyl Alcohol Cyclization Photoclick Chemistry Enabling Rapid Access to Therapeutic Oligonucleotides.

JACS Au. 2025-2-24

[4]
Workflow for E3 Ligase Ligand Validation for PROTAC Development.

ACS Chem Biol. 2025-2-21

本文引用的文献

[1]
Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs.

J Med Chem. 2023-11-23

[2]
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?

ChemMedChem. 2023-10-17

[3]
Proximity-Based Modalities for Biology and Medicine.

ACS Cent Sci. 2023-7-14

[4]
Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design.

Eur J Med Chem. 2023-8-5

[5]
Spatiotemporal and global profiling of DNA-protein interactions enables discovery of low-affinity transcription factors.

Nat Chem. 2023-6

[6]
Advancing Strategies for Proteolysis-Targeting Chimera Design.

J Med Chem. 2023-2-23

[7]
Protein degraders enter the clinic - a new approach to cancer therapy.

Nat Rev Clin Oncol. 2023-4

[8]
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.

J Med Chem. 2022-11-2

[9]
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron.

Nature. 2022-10

[10]
Target protein localization and its impact on PROTAC-mediated degradation.

Cell Chem Biol. 2022-10-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索